4-CHLORO-7-METHYL-7H-PYRROLO[2,3-D]PYRIMIDINE-5-CARBOXYLIC ACID, 95.0%, 1g

Methyl 4-methyl-3,5-dinitrobenzoate, 95.0%, 10g

Neocuproine Hydrochloride Monohydrate>99.0%(HPLC)5g

Electroporation cuvettes 100 µl 50 pcs

(3-Fluoropyridin-2-yl)methanamine hydrochloride, 95.0%, 5g

2-Pyridin-3-yl-benzaldehyde, 95.0%, 25g

4-Bromo-2-fluoro-3-methylbenzoic acid, 95.0%, 1g

Gas safety adapter accessories for cartridges, Gesch. front, Pattern C 206 GLS, 1 Piece

3,6-Dichloro-1H-pyrazolo[3,4-d]pyrimidine, 97%, 250mg

(2R,3R,4S,5S,6R)-2-[(2S,3S,4R,5R)-4-Hydroxy-2,5-bis(hydroxymethyl)-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol, 99+%, 500mg

S-Methyl-S-(4-chlorophenyl) sulfoximine, 95.0%, 250mg

2-AMINO-2-PHENYLPROPANOIC ACID, 95.0%, 250mg

6-Chloro-2-(chloromethyl)-3-fluoropyridine, 95%, 50mg